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Abstract We have identified the fifth member of the mamma-
lian X,K-ATPase L-subunit gene family. The human and rat
genes are largely expressed in skeletal muscle and at a lower level
in heart. The deduced human and rat proteins designated as
Lmuscle (Lm) consist of 357 and 356 amino acid residues,
respectively, and exhibit 89% identity. The sequence homology
of Lm proteins with known Na,K- and H,K-ATPase L-subunits
are 30.5^39.4%. Unlike other L-subunits, putative Lm proteins
have large N-terminal cytoplasmic domains containing long Glu-
rich sequences. The data obtained indicate the existence of
hitherto unknown X,K-ATPase (most probably Na,K-ATPase)
isozymes in muscle cells.
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1. Introduction
The X,K-ATPases that pump K into and Na or H out
of the cell are the most closely related P-ATPases [1,2]. They
are composed of catalytic K-subunits (V110^115 kDa) and
glycosylated L-subunits (core proteinV30^35 kDa) [2^6]. The
L-subunits, which are absent in other P-ATPases, are indis-
pensable for structural and functional maturation of X,K-
ATPases [7,8]. The X,K-ATPase family consists of three
distinct groups of ion pumps: the Na,K-ATPases, cardiac
glycoside receptors [3,4], the gastric H,K-ATPases [5] and
ouabain-sensitive, non-gastric H,K-ATPases [6,9,10]. The
K-subunits of Na,K-ATPase (four isoforms), gastric and
non-gastric H,K-ATPases exhibit V63% sequence identity
[2,11^16]. Four known X,K-ATPase L-subunits (L1, L2, L3
and Lg) share a common domain structure, but exhibit a twice
lower similarity than K-subunits [5,7,8,13].
Each of these proteins has a characteristic pattern of ex-
pression (for review, see [13]). The principle Na,K-ATPase
isozyme (K1L1) is expressed in all tissues. The K2 is largely
expressed in heart, brain and skeletal muscle, the K3 is mostly
expressed in neuronal tissue and the K4 is a testis-speci¢c
isoform [14]. The L2 expression is limited to heart, skeletal
muscle and neuronal tissue, while L3 is present in many tis-
sues. In addition to stomach, the gastric H,K-ATPase
KmRNA was traced in kidney [5]. The expression of non-
gastric H,K-ATPase K-subunits encoded by mammalian
ATP1AL1 genes was detected in colon, kidney, skin and brain
[9,10,14,16,17]. The real L-subunit of non-gastric H,K-ATPase
is unknown. Our studies indicate that a yet unidenti¢ed L-
subunit rather than any of the known ones serves as a real
counterpart of ATP1AL1 in vivo [6,10,17].
In search of a candidate for a L-subunit of non-gastric H,K-
ATPase, we detected in rat neonatal skin a transcript capable
to encode a ‘L-like’ protein. The rat and homologous human
cDNAs have been cloned and sequenced. These new members
of the X,K-ATPase L-subunit gene family are predominantly
expressed in skeletal muscles and at a lower level in hearts.
Since only traces of mRNAs were detected in skin and other
tissues, it is unlikely that these novel proteins are subunits of
the non-gastric H,K-ATPases. We term these novel L-subunits
Lmuscle (Lm). The data obtained suggest the existence of novel
distinct X,K-ATPase isozymes.
2. Materials and methods
2.1. RNA isolation
6 Months (adult) and 3 days (neonatal) old Sprague-Dawley rats
were killed by decapitation. Samples of human tissues were obtained
from the Cooperative Human Tissue Network (Columbus, OH, USA)
and from the Medical College of Ohio Hospital. Small scale total
RNA preparations were made from about 30 mg tissue using the
SV Total RNA Isolation system (Promega). For mRNA isolation,
total RNA was extracted using Trizol reagent (Life Technologies),
followed by chromatography on an oligo-(dT)-cellulose using a PolyA
Spin mRNA isolation kit (New England Biolabs).
2.2. Reverse transcription-polymerase chain reaction (RT-PCR)
Routine ¢rst strand cDNA synthesis and PCR with Taq DNA
polymerase were performed as described before [17]. The quality of
cDNA was monitored using ampli¢cation of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) cDNA [17]. For tissue-speci¢c ex-
pression studies, primer pairs DSBNF (ATCAGACCCTTCGCCCA-
TAGC, coordinates 466^486 from the initiation codon)/DSBNB
(ACGCCTTTGCCCTTCAGTTG, 988^1007) and DSRF (GATCA-
GACCCTTCGCTCATAGC, 462^483)/DSRB (GATGCCTTTGCC-
CTTCAGCTG, 985^1005) were used for human and rat tissues, re-
spectively. Most of the translated regions of both cDNAs were
ampli¢ed with primers PU (CAATGCCTGGTGGCAGAAATTG-
CAGATC, 237^264) and TU (AGATGATCGGCTGTCTTAGATG-
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TCC, 1176^1200) using Pfu DNA polymerase (Promega). The PCR
products were analyzed by gel electrophoresis.
2.3. 5P- and 3P-end regions determination by rapid ampli¢cation of
cDNA ends (RACE)-PCR
The SMART RACE cDNA Ampli¢cation kit and Advantage 2
PCR kit (Clontech) were applied according to the manufacturer’s
instructions with some modi¢cations. cDNA was synthesized with
2 Wg poly-A+ RNA and ‘Superscript I’ reverse transcriptase (Life
Technologies) for 1 h at 42‡C and 1 h at 50‡C. PCR was performed
with 1/50 of the cDNA using Advantage 2 DNA polymerase (Clon-
tech) with the supplied bu¡er, 0.2 Wm of each primer and 200 WM
dNTP. 3P-RACE was performed with primers FBNR (GATGAGG-
ACAAGAAGGCCTGCCAATTTAAACGC, 637^669) for rat and
FMHR (GATGAGGACAAGAAGGCCTGCCAATTTAAGCG,
640^671) for human cDNAs and universal primer mix (Clontech)
for 22 cycles at 94‡C (25 s), 70‡C (4 min and 25 s), followed by a
second ampli¢cation using 1/50 of the ¢rst reaction with nested prim-
ers MODNES (GGCGATCAGTGGTAACAACCCAGAGTAC)
and primers (FKR (GCTACTACCCTTACTATGGCAAACTGAC,
878^905) for rat or FK (TACTACCCTTACTACGGCAAACTGAC,
883^908) for human cDNAs) for 17 cycles at 94‡C (25 s), 60‡C (25 s),
72‡C (4 min and 25 s). 5P-RACE of both human and rat cDNA was
achieved with the human primer BMHR (CGCTTAAATTGG-
CAGGCCTTCTTGTCCTCATC, 640^671) and universal primer
mix for 28 cycles at 94‡C (25 s) 70‡C (2 min and 25 s) (for rat
cDNA, annealing at 68‡C for 25 min was included) followed by
PCR with nested primers BNNB (AGRCCTGTTCGGGCCAGAR-
ACATCC, 296^317) and MODNES for 28 cycles at 94‡C (25 s), 60‡C
(25 s), 72‡C (2 min and 25 s).
3. Results
3.1. Identi¢cation and characterization of rat and human Lm
cDNAs
In a search of the GenBank database with sequences of
known X,K-ATPase L-subunits using the TBLASTN pro-
gram, we identi¢ed a rat cDNA EST clone (Accession No
AI071721) encoding sequence of 50 amino acids with 42%
similarity to the rat L2 fragment, D75-Q124 [18], and 32%
similarity to rat Lg [19]. We used this sequence to design
primers for PCR analysis and for the ¢rst time, the existence
of a transcript was detected in rat neonatal skin cDNA. In the
majority of subsequent experiments, skeletal muscle cDNAs
were used as templates.
When the present study was in progress, a draft of three
unordered pieces of human genomic sequence from clone
DA0052J04 was deposited to the high throughput genomic
sequences division of the GenBank database (Waterston,
R.H., accession number AC006962). One of these fragments
represents a contig of 62 520 bp and was found to contain
several clusters of sequences exhibiting a high level of identity
with the rat cDNA under study. We suggested that the rat
and human sequences represent either homologous or closely
related genes. Genomic data were used to design speci¢c prim-
ers to amplify most of the coding region and to determine
5P- and 3P-ends of the cDNAs by RACE-PCR. Both human
and rat mRNAs were reconstructed by direct sequencing of
PCR products from coding regions and cloned fragments of
their 3P-untranslated regions (UTRs).
As judged from these results, both the human and rat
mRNAs are about 4.0 kbp long with short 5P-UTRs (V80
nucleotides (nt)). Their 3P-UTRs are unusually long (3.2 kbp),
being the longest among known L-subunit mRNAs.
The composite human and rat cDNA sequences generated
from these experiments contain 1074 nt and 1071 nt open
reading frames, respectively. The nucleotide and amino acid
sequence identities between human and rat isoforms are 86.5
and 89%, respectively. Thus, the rat and the human genes and
the encoded proteins are highly conserved homologues.
3.2. Structural features of Lm proteins
The primary products of human and rat gene translations
consist of 357 and 356 amino acid residues and have molec-
ular masses of 41.6 and 41.55 kDa, respectively. Coding hu-
man cDNA sequences and the deduced structures of the hu-
man and rat proteins are shown in Fig. 1.
Hydropathy analysis predicts that the transmembrane top-
ology of the putative proteins is similar to that of previously
identi¢ed X,K-ATPase L-subunits, containing a highly
charged cytoplasmic N-terminal domain followed by a trans-
membrane segment (L111-L136) and a large ectodomain
[7,8,13,20]. Other structural features speci¢c to X,K-ATPase
L-subunits include the conserved motif2 295Y(Y/F)PYYGK301,
six conserved Cys residues (201, 220, 230, 246, 269 and 329)
and four potential sites for N-glycosylation (Fig. 1). The new
proteins exhibit 30^39% of overall sequence identity with
known X,K-ATPase L-subunits [8,13,18,19,21,22].
The above indicates that the human and rat cDNAs de-
scribed here encode a new type of X,K-ATPase L-subunits
designated as Lm. The novel L-subunits exhibit a unique struc-
tural feature. Their N-terminal cytoplasmic domains are sig-
ni¢cantly larger than those of known L-subunits and contain
long Glu-rich sequences which, according to a secondary
structure prediction [23], form two long K-helices, E26-V45
and E54-E72. None of the other P-type ATPase subunits con-
tains this kind of sequence motif.
Another speci¢c feature of Lm proteins is the existence of
the variants lacking tetrapeptide 107QSWS110 (human) or
106QSRS109 (rat). This was predicted when two alternative
splice forms of cDNA, one of them lacking 12 bp, were iden-
ti¢ed in human and rat PCR products. This protein fragment
is a part of a conserved sequence (see below) which includes
the junction between cytoplasmic and membrane domains
(Fig. 1).
3.3. Organization of the human Lm gene and tissue-speci¢city of
Lm expression
Detailed sequence comparison of the human Lm cDNA with
genomic clone DA0052J04 allowed for the reconstruction of
the exon-intron structure of the Lm human gene which is
divided into eight exons (Fig. 1). All splice donor and accept-
or sequences conform to the standard consensus (data not
shown) [24]. Two di¡erent donor sites at the exon 2-intron
2 boundary (Fig. 1) have been used in the alternative splicing
event described above. The exon organization of the Lm gene
and locations of the exon/intron boundaries relative to the
protein sequence are quite similar to that of L-subunit genes
[25]. The L1 gene contains six exons, whereas those of L2, L3
and Lg are divided into seven exons [25]. The additional exon
in the Lm gene encodes the extreme N-terminal domain which
has no homology in other L-subunits. This similarity is con-
sistent with the view that all these genes originated from a
common evolutionary ancestor.
Screening of the STS division of the GenBank database
2 Here and throughout, all amino acid numbering in the text is in-
dicated according to the human Lm sequence.
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revealed sequence identity of two regions of human Lm cDNA
corresponding to exons 4 and 8 of the gene, with the X chro-
mosome sequence-tagged sites stSG34617 and stSG45811.
These data indicate that the human Lm gene is located on
the X chromosome.
A qualitative analysis of the Lm gene expression in various
rat and human tissues was done using RT-PCR. A prominent
signal was observed in skeletal muscle and a weaker one in
heart tissue (Fig. 2). In other tissues tested, only a trace or no
expression was detected. The list of rat tissues with trace ex-
pression is: skin, uterus, lung, pancreas, prostate, esophagus,
vena cava, adrenal, adipose tissue, uterus, ovary, stomach,
spleen, vas deferens and thymus. The transcript seems to be
absent in testis, preputial, vesicular and coagulating glands,
kidney, liver, bone marrow, colon mucosa, brain and duode-
num. Human tissues tested and found to almost or completely
lack the transcript are skin, jejunum, uterus, brain, prostate,
liver, skin, kidney and placenta.
Di¡erent rat skeletal muscles (diaphragm, tongue, soleus
and extensor digitorum longum) showed the presence of the
transcript without a dramatic di¡erence in the expression level
(results not shown).
These data allowed us to conclude that the gene exhibits a
muscle-speci¢c expression pattern being especially abundant
Fig. 1. Nucleotide sequence of the human X,K-ATPase Lm subunit and deduced amino acid sequences of human and rat Lm proteins. The hu-
man nucleotide sequence is shown above the deduced amino acid sequences of human and rat proteins. Nucleotides and amino acids are num-
bered to the right of the sequences beginning with the initiating ATG and Met, respectively. Consensus sequences of potential sites of N-glyco-
sylation are underlined. Non-conserved amino acid residues are marked by asterisks. Positions of the introns in the human gene are indicated
by arrows, lowercase letters and £anked by exon numbers. The sequence of the alternative splicing site and corresponding amino acid residues
are depicted by lowercase letters.
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in skeletal muscle and at a lower level in heart. In other adult
tissues, the expression seems to be absent or at a trace level
that may be attributed to smooth muscle cells. The initial
detection of the transcript in rat skin may be due to the
presence of skeletal muscles in the samples used. To underline
muscle-speci¢c patterns of expression, we termed these novel
L-subunits Lm.
4. Discussion
We have identi¢ed the human and rat cDNAs encoding a
novel muscle-speci¢c X,K-ATPase Lm subunit whose existence
Fig. 3. Comparison of the amino acid sequences of the human X,K-ATPase Lm subunit, L1-, L2- and L3-isoforms of human Na,K-ATPase (L1,
L2 and L3) and human gastric H,K-ATPase L-subunit (Lg). The following sequences were obtained from the GenBank database: L1
(NM_001677), L2 (NM_001678), L3 (NM_001679) and Lg (NM_000705). The amino acid sequence of Lm and identical residues in other pro-
teins are shaded. Gaps (represented by dashes) were introduced to maintain the alignment. Transmembrane domains are underlined. Conserved
cysteines are indicated by asterisks. The amino acids are numbered at the right of the sequences.
Fig. 2. RT-PCR analysis of tissue-speci¢c expression of the X,K-
ATPase Lm-subunit. (A) Ampli¢cation products of the Lm mRNA.
(B) Control ampli¢cation of GAPDH. 2a: Rat: 1, brain; 2, skeletal
muscle; 3, heart; 4, skin; 5, duodenum; 6, uterus. 2b: Human:
1, brain (cortex, white matter and meninges); 2, skeletal muscle;
3, heart; 4, skin; 5, jejunum; 6, uterus (myometrium).
6
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was not predicted in previous biochemical and physiological
studies on P-type ATPases in heart and skeletal muscles. Dis-
covery of the Lm proteins has substantially expanded the pos-
sibility for a more detailed analysis of structural relatedness
between di¡erent members of the X,K-ATPase L-subunit gene
family (Fig. 3).
In respect to sequence homology, rat and human Lm pro-
teins (89.1% identity) occupy an intermediate position be-
tween extremely conserved L1 (94.4%) and L2 (96.2%) and
more divergent Lg (81.4%) and L3 (74.9%) [8,13,25]. The hu-
man Lm protein exhibits 39.4% identity with the L2 sequence
[18], 32.6% with L1 [21], 35.1% with L3 [22] and 33.4% with Lg
[19]. The similarities of corresponding cDNA sequences are
45.4, 40.8, 30.7 and 45.6%, respectively. Thus, Lm is slightly
more related to L2 and almost equally distant from all other
L-subunits.
All X,K-ATPase L-subunits exhibit characteristic features,
such as the presence of three disul¢de bridges within all L-
ectodomains. There are 2^8 (L3 and L2, respectively) sites of
N-glycosylation in human L-isoforms [8,18,22,25]. Locations
of these sites in the polypeptides are not conserved and only
one motif, 227LXNCS231 (X = any residue), is present in all
human proteins except L3.
Data obtained allowed us to trace several other conserved
stretches of amino acids. The most prominent examples of
these sequences are 101(F/M)-(L/M)-(A/G)-R-T-X-X-(S/R)-
W-X-X-I-(L/S)-L-(X)3-F-Y120, 220C-X-F-(X)5-L-X-(N/A)-C-S-
G-X-X-D-(X)3-(F/Y)-G-(Y/F)-X-X-G-X-P-C-(X)3-K-M-N-R-
(I/V)-(I/V)255 and 291(F/I)-X-L-X-Y-(Y/F)-P-Y-Y-G-K-(K/L)-
X-(H/Q)-(V/P)-X-Y-X-X-P-L-(V/L)-A313. We consider these
conserved motifs as signature sequences that may simplify
the search of hitherto unknown L-subunits.
As it was mentioned above, the Lm is the only known P-
ATPase subunit with the long Glu-rich N-terminus. Acidic
domains including oligo-Glu or oligo-Asp stretches are suspi-
ciously frequent in Ca-binding and Ca-transporting proteins
in muscle cells, such as ryanodine receptor, voltage-gated cal-
cium channel, calsequestrin, calreticulin, etc. (see for review
[26]). From this, one can speculate that the acidic N-terminal
domain of Lm may be a Ca-binding site with a potential of
Ca-dependent regulation of X,K-ATPase(s).
The highly speci¢c expression pattern of the Lm gene and
the structural features of the Lm protein suggest its specialized
function in the muscle cells. It is known that skeletal muscles
contain several Na,K-ATPase isoforms but gastric and non-
gastric H,K-ATPases are absent. The K1 and K2 are expressed
in both muscle ¢ber types while expression of L-subunits is
muscle type-speci¢c: L1 is abundant in slow oxidative type
muscles while L2 is restricted to fast glycolytic ¢bers [27].
The skeletal muscle Na,K-ATPase constitutes the major
pool of the organism and its regulation is important for plas-
ma K-homeostasis under some conditions. Signi¢cant aug-
mentation of skeletal muscle Na,K-ATPase during training is
thought to increase the plasma K-clearance capacity [28^30].
Downregulation of the skeletal muscle ATPase in hypokale-
mia [31^33] is controlled by the central nervous system [34]
and is isoform- and muscle type-speci¢c: it is substantial only
for K2 and L2 genes and is more pronounced in glycolytic
muscles [35].
Interestingly, the total pool of L1 and L2 proteins in skeletal
muscle was reported to be several fold higher than the total
pool of K-subunits (unlike kidney and brain where the ratio is
about 1:1) [36]. It was suggested that the ratio of L- to K-
subunits may serve to regulate the catalytic activity of Na,K-
ATPase in skeletal muscle [37]. The identi¢cation of yet an-
other L-subunit adds a new aspect to this problem and makes
the situation even more complex.
The novel Lm-subunit cannot a priori be classi¢ed as a
subunit of the Na,K-ATPase. The possibility cannot be ex-
cluded that Lm is a component of an unknown X,K-ATPase
whose catalytic subunit is not identi¢ed. Also, it cannot be
excluded that Lm may have a function apart from its role of
X,K-ATPase subunit, similar to L2 which acts as an adhesion
molecule [7,8].
Identi¢cation of this novel L-isoform shows that the diver-
sity of X,K-ATPases is still underestimated and also suggests
a possibility that yet some other unknown L-isoforms are to
be discovered. The physiological signi¢cance of the human L-
isoform diversity and nature of potential tissue-speci¢c and
developmental regulation of K-L-subunits pairing remains to
be a goal of future studies.
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